CPT2 and cancer: It has been shown that inhibition of CPT1 reduces FAO efficiency, which in turn weakens lymphangiogenesis in pathological states such as cancer, while excess lymphangiogenesis favors cancer metastasis (Wong et al., 2017; Li et al., 2021).